Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study (vol 17, 714026, 2021)

被引：2

作者：

Jiang, Xiao ^{[1
]}

Huang, Chun-Mei ^{[2
]}

Feng, Chun-Mei ^{[3
]}

Xu, Zheng ^{[3
]}

Fu, Lin ^{[3
,4
]}

Wang, Xin-Ming ^{[5
,6
]}

机构：

[1] Anhui Med Univ, Affiliated Hosp 1, Dept Nephrol, Hefei, Peoples R China

[2] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Anhui Prov Key Lab Major Autoimmune Dis, Hefei, Peoples R China

[3] Anhui Med Univ, Affiliated Hosp 2, Resp & Crit Care Med, Hefei, Peoples R China

[4] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China

[5] Anhui Med Univ, Affiliated Hosp 1, Dept Pharm, Hefei, Peoples R China

[6] Third Grade Pharmaceut Chem Lab State Adm Tradit, Hefei, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2022年 / 12卷

关键词：

S100A12; community-acquired pneumonia; CAP severity score; prognosis; biomarker;

D O I：

10.3389/fimmu.2021.815903

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：1